PofoliaShared via Pofolia

Medical Sciences· 2023Q1

Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma

Adam Barsouk, John Sukumar Aluru, Prashanth Rawla, Kalyan Saginala et al.

Short summary

Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer globally, with 890,000 new cases and 450,000 deaths annually. Risk factors vary by region, including tobacco, alcohol, and areca nut in developing nations, and HPV in developed nations.

AI-generated from the title and abstract; the full text is not read.

Key points

  • HNSCC accounts for 4.5% of global cancer diagnoses and deaths, with 890,000 new cases and 450,000 deaths annually.
  • Synergistic heavy consumption of alcohol and tobacco increases HNSCC risk up to 40-fold.
  • HPV-related HNSCC, common in developed nations, has a median survival of 130 months compared to 20 months for other HNSCC types.
  • Disparities in lifestyle, healthcare access, and etiology contribute to higher HNSCC incidence and poorer survival in minority and lower-socioeconomic communities.

AI-generated from the title and abstract; the full text is not read.

Abstract

Head and neck squamous cell carcinoma (HNSCC) is a group of malignancies, involving the oral cavity, pharynx, hypopharynx, larynx, nasal cavity, and salivary glands, that together compose the seventh most common cancer diagnosis worldwide. With 890,000 new cases and 450,000 deaths annually per GLOBOCAN estimates, HNSCC accounts for roughly 4.5% of cancer diagnoses and deaths. In the developing world, the incidence of HNSCC is growing with increasing consumption of tobacco (smoked or chewed), alcohol, and areca nut (betel quid). Alcohol and tobacco have a synergistic effect, with the heavy consumption of both increasing HNSCC risk 40-fold. In developed nations, HPV-related HNSCC surpasses tobacco- and alcohol-related disease. HPV-related HNSCC more commonly affects the oropharynx, hypopharynx, and larynx than the oral cavity, and is associated with a significantly longer median survival (130 months vs. 20 months). Discrepancies in etiology as well as disparities in lifestyle choices and access to healthcare may account for the greater incidence and poorer survival of HNSCC among minority and lower-socioeconomic-status communities in developed nations. Pharmacotherapy and counseling together have been shown to be effective in promoting smoking and alcohol cessation. Education on cancer risk and community engagement have reduced areca nut consumption in Asia as well as in diaspora communities. HPV vaccination, starting at age 11-12 for both sexes, has been shown to reduce the prevalence of high-risk HPV serologies and prevent pre-cancerous lesions of the cervix, vagina, and vulva. As of 2020, 58.6% of eligible adolescents in the US have received the full two-vaccine series. Increased adoption of vaccination, education on safe sex practices, and routine visual oral screening for high-risk patients would curb growing HNSCC incidence in developed nations.

The authors' abstract, as published at the source. Medical Sciences, 2023 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Otorhinolaryngology

OtorhinolaryngologyMedicine